Our client needed to launch a new treatment for patients with two of the three forms of sclerosis: Recurrent forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS). We designed and developed guidelines for the launch and adoption of a new treatment, based on a deep understanding of the Multiple Sclerosis patient’s journey in the Private Sector, and based on the role of different stakeholders involved in the treatment of the disease.
Main objectives:
- Mapping the patient’s journey with Multiple Sclerosis in the private sector.
- Understanding the logic of medical prescription and purchase of treatments.
- Definition of guidelines for the launch and the future adoption of the treatment.
PATIENT JOURNEY MAP
PATIENT AND STAKEHOLDER OBSERVATIONS AND IN-DEPTH INTERVIEWS
ROCHE IDEATION SESSIONS
ANALYSIS & IDEATION
Andres Ortega 